View in EDS

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.

Saved in:
Bibliographic Details
Title: Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.
Authors: Brody JD; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY., Jørgensen J; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Belada D; 4th Department of Internal Medicine, Hematology, University Hospital and Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic., Costello R; Service d'Hematologie et Thérapie Cellulaire, Assistance Publique Hôpitaux de Marseille, Marseille, France., Trněný M; First Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Vitolo U; Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy., Lewis DJ; Department of Haematology, Derriford Hospital, University Hospitals Plymouth National Health Service Trust, Plymouth, United Kingdom., Karimi YH; University of Michigan Division of Hematology & Oncology, Ann Arbor, MI., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia, L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., André M; Service d'Hématologie, Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir, Belgium., Wahlin BE; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Jiang T; Oncology Clinical Development, AbbVie, North Chicago, IL., Karagoz K; Translational Data Science, Genmab, Plainsboro, NJ., Steele AJ; Translational Medicine, Genmab, Plainsboro, NJ., Abbas A; Clinical Science, Genmab, Plainsboro, NJ., Wang L; Biostatistics, Genmab, Plainsboro, NJ., Risum M; Medical, Genmab, Copenhagen, Denmark., Cordoba R; Department of Hematology, Fundación Jiménez Diaz University Hospital, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Madrid, Spain.
Source: Blood [Blood] 2025 Apr 10; Vol. 145 (15), pp. 1621-1631.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study; Clinical Trial, Phase I
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39792928
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brody+JD%22">Brody JD</searchLink>; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.<br /><searchLink fieldCode="AU" term="%22Jørgensen+J%22">Jørgensen J</searchLink>; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Belada+D%22">Belada D</searchLink>; 4th Department of Internal Medicine, Hematology, University Hospital and Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Costello+R%22">Costello R</searchLink>; Service d'Hematologie et Thérapie Cellulaire, Assistance Publique Hôpitaux de Marseille, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Trněný+M%22">Trněný M</searchLink>; First Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Vitolo+U%22">Vitolo U</searchLink>; Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Lewis+DJ%22">Lewis DJ</searchLink>; Department of Haematology, Derriford Hospital, University Hospitals Plymouth National Health Service Trust, Plymouth, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Karimi+YH%22">Karimi YH</searchLink>; University of Michigan Division of Hematology & Oncology, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Sureda+A%22">Sureda A</searchLink>; Clinical Hematology Department, Institut Català d'Oncologia, L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22André+M%22">André M</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir, Belgium.<br /><searchLink fieldCode="AU" term="%22Wahlin+BE%22">Wahlin BE</searchLink>; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lugtenburg+PJ%22">Lugtenburg PJ</searchLink>; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jiang+T%22">Jiang T</searchLink>; Oncology Clinical Development, AbbVie, North Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Karagoz+K%22">Karagoz K</searchLink>; Translational Data Science, Genmab, Plainsboro, NJ.<br /><searchLink fieldCode="AU" term="%22Steele+AJ%22">Steele AJ</searchLink>; Translational Medicine, Genmab, Plainsboro, NJ.<br /><searchLink fieldCode="AU" term="%22Abbas+A%22">Abbas A</searchLink>; Clinical Science, Genmab, Plainsboro, NJ.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Biostatistics, Genmab, Plainsboro, NJ.<br /><searchLink fieldCode="AU" term="%22Risum+M%22">Risum M</searchLink>; Medical, Genmab, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Cordoba+R%22">Cordoba R</searchLink>; Department of Hematology, Fundación Jiménez Diaz University Hospital, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 Apr 10; Vol. 145 (15), pp. 1621-1631.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39792928
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2024026830
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1621
    Titles:
      – TitleFull: Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brody JD
      – PersonEntity:
          Name:
            NameFull: Jørgensen J
      – PersonEntity:
          Name:
            NameFull: Belada D
      – PersonEntity:
          Name:
            NameFull: Costello R
      – PersonEntity:
          Name:
            NameFull: Trněný M
      – PersonEntity:
          Name:
            NameFull: Vitolo U
      – PersonEntity:
          Name:
            NameFull: Lewis DJ
      – PersonEntity:
          Name:
            NameFull: Karimi YH
      – PersonEntity:
          Name:
            NameFull: Sureda A
      – PersonEntity:
          Name:
            NameFull: André M
      – PersonEntity:
          Name:
            NameFull: Wahlin BE
      – PersonEntity:
          Name:
            NameFull: Lugtenburg PJ
      – PersonEntity:
          Name:
            NameFull: Jiang T
      – PersonEntity:
          Name:
            NameFull: Karagoz K
      – PersonEntity:
          Name:
            NameFull: Steele AJ
      – PersonEntity:
          Name:
            NameFull: Abbas A
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Risum M
      – PersonEntity:
          Name:
            NameFull: Cordoba R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 04
              Text: 2025 Apr 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 145
            – Type: issue
              Value: 15
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1